Crossmark

Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression

Crossref DOI link: https://doi.org/10.1007/s00277-018-3480-9

Published Online: 2018-08-29

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiaosu, Zhao

Leqing, Cao

Yazhen, Qin

Yu, Wang

Xiaohui, Zhang

Lanping, Xu

Xiaojun, Huang

Yingjun, Chang
License Information

Text and Data Mining valid from 2018-08-29
More Information

Article History

Received: 18 July 2018

Accepted: 14 August 2018

First Online: 29 August 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below